Resources

A Phase-1b Dose Escalation Study to Assess the Effect of NG11-2 on Radiation Induced Oral Mucositis (RIOM) in Patients with Head & Neck Cancer.

In this blog, BIA member Brainomix, following its series C round, answers questions on the company's origins and future trajectory.

ELRIG, a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D site in Gothenburg, Sweden from 14–15 May. Prof Rory Johnson, Associate Professor, University College Dublin, and Dr Shalini Andersson, Vice President Nucleic Acid Therapeutics, AstraZeneca will lead this year’s event focussed on ‘drugging the undruggable’.

Imperial Incubator and Imperial College Healthcare NHS Trust have announced new partnerships with ARC West London, designed to support innovators across AI, life sciences, robotics and digital industries to scale, further bolstering the thriving West London life sciences ecosystem.

o2h discovery is excited to announce Ubiquigent as a winner of the o2h Kickstarter Competition. Ubiquigent Limited (Ubiquigent), a revenue- and IP-generating drug discovery company dedicated to enabling deubiquitinase (DUB)-focused drug discovery.

Emerson partners with biopharmaceutical companies to drive innovation, efficiency, and compliance in life sciences manufacturing through cutting-edge automation and process expertise. As a new BIA member, Emerson is committed to helping manufacturers streamline production, ensure product quality, and accelerate time to market for life-saving therapies. In this blog, David introduces the company's latest white paper.

Cancer Research Horizons launches the Cancer Impact Club, a community of business builders whose philanthropy, expertise and networks will help shape the future of cancer treatment.

Proteintech has announced a new initiative in product characterization using AI, improving the speed and precision of antibody selection for scientists.

University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated impact on vital treatments.

Poolbeg Pharma announces that the Korean Intellectual Property Office has notified the Company of its official decision to grant Poolbeg's Republic of Korea Immunomodulator II patent application providing protection to POLB 001 for the treatment of severe influenza to December 2038.  

Dr Edward Green, CEO of Aberdeen-based biotech company NCIMB Ltd has won the Business Leadership Award at Scotland’s Life Sciences Awards.

Life science innovation company ValiRx has announced the appointment of a Director of Research and expanded the lab team of its research subsidiary, Inaphaea BioLabs.

Coulter Partners successfully completed a search assignment for ExpressionEdits and is pleased to announce the placement of Dr. Amrik Basran as Chief Scientific Officer (CSO).

The 2024 Bionow Awards dinner marked an exceptional evening of recognition and celebration, as 342 distinguished guests gathered at the Concorde Conference Centre on 6 March to honour those who have demonstrated outstanding ingenuity and dedication.

The Wilton Centre - one of 12 Pioneer Group sites - could provide the answer after a study highlighted the shortage of commercial laboratory space in the North East of England.

Innovate UK has announced an investment over £14 million across 29 innovative projects to help make the UK’s medicines manufacturing sector more sustainable.

Arecor establishes partnership with biopharmaceutical company to develop novel formulation of peptide therapy.

RoslinCT has entered into a strategic partnership with Gamida Cell Ltd. to manufacture their FDA-Approved Cell Therapy Omisirge.®

From Friday, 7 to Sunday, 16 March, British Science Week 2025 is a chance to celebrate everything about science and the amazing contributions made by professionals within this field. This year’s theme, “Change and Adapt,” encourages us to reflect on how humans, animals, and technology evolve to meet the challenges of a growing population and changing environment.

Gastronomica, the state-of-the-art food and drink incubator, officially launched at Pioneer Group’s Colworth Science Park on 5 March.